The DOI matches its Crossref record; 26 of the 29 references it cites were found in a registry or an index.
Pattern of use and subjective effects of Salvia divinorum among recreational users
Abstract
Background Salvia divinorum is a member of the Lamiaceae family and contains the psychotropic diterpene and kappa-opioid receptor agonist salvinorin-A. Originally a shamanic inebriant used by the Mexican Mazatec Indians, the plant and its preparations are becoming increasingly popular among non-traditional users.Methods Demographic data and information on pattern of use and subjective effects were obtained by means of self-report questionnaires from a sample of 32 recreational users of salvia and other psychedelics.Results Involvement with salvia appeared to be a recent phenomenon. Smoking the extract was the preferred form of administration. Subjective effects were described as intense but short-lived, appearing in less than 1 min and lasting 15 min or less. They included psychedelic-like changes in visual perception, mood and somatic sensations, and importantly, a highly modified perception of external reality and the self, leading to a decreased ability to interact with oneself or with one's surroundings.Conclusions Although some aspects of the subjective effects reported were similar to high doses of classical psychedelics with serotonin-2A receptor agonist activity, the intense derealization and impairment reported appear to be a characteristic of salvia. The observed simultaneous high scores on the LSD and PCAG subscales of the Addiction Research Center Inventory (ARCI) have been previously reported for other kappa-opioid agonists, and support kappa receptor activation as the probable pharmacologic mechanism underlying the modified state of awareness induced by salvia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Kappa receptor agonists induce anxiogenic and dysphoric effects in humans (141-143) and depressive-like behavior in animals (i.e., increased immobility in the forced swim test) (144, 145).”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [142]
Citations
Cites
(1970) · Cited by 24,983
Martin, W. R., Sloan, J. W., SAPIRA, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 945
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182234399 · Cited by 784
The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390
Self-citationRiba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303
Self-citationSalvia divinorum and salvinorin A: new pharmacologic findings
Siebert, D. J. (1994) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)90116-3 · Cited by 280
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Walsh, S., Strain, E., Abreu, M., & Bigelow, G. (2001) · Psychopharmacology · doi:10.1007/s002130100788 · Cited by 258
Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae)
Ortega, A. R., Blount, J. F., & Manchand, P. S. (1982) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19820002505 · Cited by 226
Chavkin, C., Sud, S., Jin, W., Stewart, J., Zjawiony, J. K., Siebert, D. J., Compton-Toth, B. A., Hufeisen, S. J., & Roth, B. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059394 · Cited by 210
Valdés, L. J., Butler, W. M., Hatfield, G. M., Paul, A. G., & Koreeda, M. (1984) · The Journal of Organic Chemistry · doi:10.1021/jo00198a026 · Cited by 175
Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling AND Játiva-M.)
Valdés, L. J., Díaz, J., & Paul, A. G. (1983) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(83)90004-1 · Cited by 166
Gouzoulis‐Mayfrank, E., Thelen, B., Habermeyer, E., Kunert, H. J., Kovar, K. ‐., Lindenblatt, H., Hermle, L., Spitzer, M., & Sass, H. (1999) · Psychopharmacology · doi:10.1007/s002130050860 · Cited by 145
Adaptive sampling in research on risk-related behaviors
Thompson, S. K., & Collins, L. M. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00215-6 · Cited by 130
Butelman, E. R., Harris, T. J., & Kreek, M. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1638-0 · Cited by 102
Psychometric assessment of the Hallucinogen Rating Scale☆
Riba, J., Rodrı́guez-Fornells, A., Strassman, R. J., & Barbanoj, M. J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00175-7 · Cited by 88
Self-citationA New Mexican Psychotropic Drug from the Mint Family
Wasson, R. G. (1962) · Botanical Museum leaflets Harvard University · doi:10.5962/p.168538 · Cited by 83
Evaluation of Herbal Dietary Supplements Marketed on the Internet for Recreational Use
Dennehy, C. E., Tsourounis, C., & Miller, A. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g185 · Cited by 80
Riba, J., Rodríguez‐Fornells, A., & Barbanoj, M. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1237-5 · Cited by 70
Self-citationUse of Nonprohibited Hallucinogenic Plants: Increasing Relevance for Public health?
Bücheler, R., Gleiter, C. H., Schwoerer, P., & Gaertner, I. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-837763 · Cited by 63
Bringing Ayahuasca to the Clinical Research Laboratory
Riba, J., & Barbanoj, M. J. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399804 · Cited by 59
Self-citationZacny, J. P., Hill, J. L., Black, M. L., & Sadeghi, P. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37712-2 · Cited by 56
Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI)
Lamas, X., Farré, M., Llorente, M., & Camı́, J. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90075-2 · Cited by 55
Arasteh, K., Poudevida, S., Farré, M., Roset, P. N., & Camı́, J. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00185-9 · Cited by 10
Research works printed but not linked: 2
- Ott, 1995, Ethnopharmacognosy and human pharmacology of Salvia divinorum and salvinorin A, Curare, 18, 103
- Wasson, 1962, vol. 20
Cited by
Sorted by citations
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
Drugs as instruments: A new framework for non-addictive psychoactive drug use
Müller, C. P., & Schumann, G. (2011) · Behavioral and Brain Sciences · doi:10.1017/s0140525x11000057 · Cited by 286
A brain-centric model of suicidal behavior
Mann, J. J., & Rizk, M. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081224 · Cited by 214
Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits
Camilleri, M., Lembo, A., & Katzka, D. A. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.05.014 · Cited by 176
Metadata
- Authors
- González, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., & Barbanoj, M. J.
- Affiliations
- Universidad Autónoma de Madrid (ES)
- Universitat Autònoma de Barcelona (ES)
- Corresponding author
- Barbanoj, Manel J.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 85
- Issue
- 2
- Pages
- 157-162
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2168830964
- Cited by
- 163
- References
- 29
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 12 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 19
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- Salvia divinorum, salvinorin A, kappa opioid receptor agonists, recreational drug use, subjective effects, derealization, psychedelic effects, Addiction Research Center Inventory
- MeSH terms
- Adult, Affect, Cross-Sectional Studies, Diterpenes, Euphoria, Female, Humans, Male, Perception, Plant Extracts, Reality Testing, Retrospective Studies, Sensation, Spain, Illicit Drugs, Receptors, Opioid, kappa, Substance-Related Disorders, Salvia, Diterpenes, Clerodane
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review